Blood somatostatin in obesity
Epshteĭn, E.V.
Sovetskaia Meditsina 2: 33-36
1981
ISSN/ISBN: 0038-5077 PMID: 6113692 Document Number: 177922
Document emailed within 1 workday
Related Documents
Hua, Q.; Tan, J.; Liu, Z-hui.; Liu, R-kun.; Yang, Z. 2007: A cohort study on the correlation between birth weight, simple obesity, blood lipids, blood glucose and blood pressure from childhood to adolescence Zhonghua Nei Ke Za Zhi 46(11): 923-925O'Carroll, A.M.; Lolait, S.J.; König, M.; Mahan, L.C. 1993: Molecular cloning and expression of a pituitary somatostatin receptor with preferential affinity for somatostatin: 28 Molecular Pharmacology 44(6): 1278
Yoshioka, M. 1986: Elevation of somatostatin content, and reduction of somatostatin release by GABA in rat pancreatic islets Kobe Journal of Medical Sciences 32(1): 27-38
Padberg, W.M.; Morgalla, H.; Buhr, J.; Hild, P.; Schwemmle, K. 1991: Immunosuppressive action of somatostatin and the somatostatin analogue SMS 201-995 and their synergistic effect with low-dose cyclosporine a in organ transplantation Transplantation Proceedings 23(1 Part 1): 348
Whitehouse, I.; Beglinger, C.; Fried, M.; Gyr, K. 1984: The effect of an octapeptide somatostatin analogue (SMS 201-995) and somatostatin-14 (SST-14) on pentagastrin-stimulated gastric acid secretion: a comparative study in man Hepato-Gastroenterology 31(5): 227-229
Gorden, P.; Comi, R.J.; Maton, P.N.; Go, V.L. 1989: NIH conference. Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone-secreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut Annals of Internal Medicine 110(1): 35-50
Estève, J.P.; Susini, C.; Vaysse, N.; Gineston, J.L.; Pradayrol, L.; Wunsch, E.; Ribet, A. 1982: Effect of somatostatin 14, as natural and synthetic somatostatin 28 on pentagastrin-stimulated gastric acid and pancreatic secretions in conscious dogs Gastroenterologie Clinique et Biologique 6(6-7): 576-580
Vainas, I.; Koussis, C.; Pazaitou-Panayiotou, K.; Drimonitis, A.; Chrisoulidou, A.; Iakovou, I.; Boudina, M.; Kaprara, A.; Maladaki, A. 2004: Somatostatin receptor expression in vivo and response to somatostatin analog therapy with or without other antineoplastic treatments in advanced medullary thyroid carcinoma Journal of Experimental and Clinical Cancer Research: Cr 23(4): 549-559
Claro, A.; Grill, V.; Efendić, S.; Luft, R. 1977: Studies on the mechanisms of somatostatin action on insulin release. IV. effect of somatostatin on cyclic AMP levels and phosphodiesterase activity in isolated rat pancreatic islets Acta Endocrinologica 85(2): 379-388
Nikou, G.C.; Lygidakis, N.J.; Toubanakis, C.; Pavlatos, S.; Tseleni-Balafouta, S.; Giannatou, E.; Mallas, E.; Safioleas, M. 2005: Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues Hepato-Gastroenterology 52(63): 731-741
Slavnov, V.N.; Epshteĭn, E.V.; Efimov, A.S.; Luchitskiĭ, E.V. 1981: Relation between blood somatostatin concentration and somatotropin, insulin and glucagon secretion in endocrine diseases Problemy Endokrinologii 27(2): 3-6
Jaquet, P.; Gunz, G.; Saveanu, A.; Barlier, A.; Dufour, H.; Taylor, J.; Dong, J.; Kim, S.; Moreau, J.P.; Culler, M.D. 2005: BIM-23A760, a chimeric molecule directed towards somatostatin and dopamine receptors, vs universal somatostatin receptors ligands in GH-secreting pituitary adenomas partial responders to octreotide Journal of Endocrinological Investigation 28(11 Suppl International): 21-27
Koc, E.U.; Ozgur, T.; Yerci, O.; Gurel, S. 2013: Somatostatin receptor 1 (SSTR1) and somatostatin receptor 5 (SSTR5)expression in hepatocellular carcinoma Hepato-Gastroenterology 60(127): 1693-1697
Tocchi, A.; Costa, G.; Lepre, L.; Liotta, G.; Mazzoni, G.; Miccini, M. 1999: Effects of octreotide (somatostatin analog SMS 201-995) on superior mesenteric artery blood flow in swine. An experimental study using Doppler color ultrasonography Il Giornale di Chirurgia 20(1-2): 9-13
Holzgreve, H. 1980: Problems and errors in the measuring and interpretation of blood pressure. Part 7. Blood pressure determination in obesity Münchener Medizinische Wochenschrift 122(41 Suppl): 56-60
Gillum, R.F. 1991: Blood groups, serum cholesterol, serum uric acid, blood pressure, and obesity in adolescents Journal of the National Medical Association 83(8): 682-688
Hofland, L.J. 2003: Responsiveness to somatostatin analog treatment and potentials of novel somatostatin analog Journal of Endocrinological Investigation 26(8 Suppl): 8-13
Roshan, J.; Ganesh, A. 2002: Tibolone, blood pressure and obesity National Medical Journal of India 15(3): 180
Cerasola, G.; Verga, S.; Cottone, S.; Donatelli, M.; Vaccaro, M.; Contorno, A.; Bompiani, G. 1988: Correlations between islet-pancreatic activity and blood pressure in obesity Cardiologia 33(2): 169-173
Belinskiĭ, V.P. 1991: Dynamics of body fat mass and blood circulation in young men with obesity Vrachebnoe Delo 6: 48-51